IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Cytokine - Vol. 149 (2021), p. 155730

Language:

English

Contributors:

Kow, Chia Siang
Zaihan, Abdullah Faiz
Ramachandram, Dinesh Sangarran
Hasan, Syed Shahzad

Links:

Volltext

Keywords:

COVID-19
Corticosteroid
IL-6 antagonist
Journal Article
Sarilumab
Tocilizumab

Notes:

Date Revised 26.11.2021

published: Print-Electronic

Citation Status In-Process

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1016/j.cyto.2021.155730

PMID:

34628129

PPN (Catalogue-ID):

NLM33282909X